Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines

Both calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) and OnabotulinumtoxinA (botox) are used in the prevention of chronic migraines. However, it is not clear which is more effective overall. This review will compare the efficacy, side effects, cost-effectiveness, and other factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Mariah, Shah, Parth V, Balani, Prachi, Lopez, Angel R, Nobleza, Chelsea Mae N, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Medical Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847775/
https://www.ncbi.nlm.nih.gov/pubmed/33542885
http://dx.doi.org/10.7759/cureus.13002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847775/
https://www.ncbi.nlm.nih.gov/pubmed/33542885
http://dx.doi.org/10.7759/cureus.13002

Ejemplares similares